GSK ploughs $95m into research institute
June 17, 2015Research and Development, Sales and Marketing GSK, Pfizer, acquisition, altius, merger, takeover
GlaxoSmithKline is pouring $95 million into a new US research institute to investigate how a cell’s operating system works in …
Immodulon Therapeutics makes two senior hires
June 17, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Immodulon Therapeutics
UK late-stage biopharma firm Immodulon Therapeutics has made two new senior appointments to its board of directors. Investment fund manager …
Actavis changes its name to Allergan
June 16, 2015Medical Communications, Sales and Marketing Actavis, Allergan, Botox, Valeant
Actavis has now officially changed its name to Allergan following the Ireland-based company’s recent acquisition of the botox maker. This …
Pfizer expands in China with $95m consumer products plant
June 16, 2015Manufacturing and Production, Sales and Marketing Asia, China, Pfizer, brett wells, production
Pfizer says it has broken ground with a $95 million production facility in Suzhou in China to expand its production …
FDA links with PatientsLikeMe
June 16, 2015Medical Communications, Sales and Marketing FDA, PatientsLikeMe, data
The US Food and Drug Administration has signed a research deal with PatientsLikeMe in a move the online patient network …
Rock Unlimited appoints director
June 16, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ben fisher, rock unlimited
Communications firm Rock Unlimited has appointed a new director to its team in Ben Fisher. Fisher takes to the firm …
FDA accepts Teva asthma drug for review
June 15, 2015Sales and Marketing AstraZeneca, GlaxoSmithKline’s mepolizumab, Teva, benralizumab, bla, cinquil, reslizumab
Teva’s investigational biologic for the treatment of inadequately controlled asthma in patients with elevated blood eosinophils, Cinquil, has been accepted …
Bayer promotes Xarelto benefits
June 15, 2015Sales and Marketing Bayer, Eliquis, Xarelto, blood, law suits, rivaroxaban
Bayer HealthCare is releasing new evidence to suggest that the risk of taking its best-selling blood thinner Xarelto is outweighed …
Consumer watchdog highlights FDA failures
June 15, 2015Manufacturing and Production, Research and Development, Sales and Marketing FDA, brett wells, hetlioz, public citizen
Consumer watchdog Public Citizen has criticised the FDA for incorrectly expanding the use of Vanda Pharma’s sleep disorder drug Hetlioz …
Amgen bets on immunotherapy future
June 15, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, immunotherapy, oncology, oncolytic, tom lillie
When we speak to Tom Lillie he’s brimming with excitement about the future for Amgen in oncology and the future …
DrugDev looks to Lilly for chairman role
June 15, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drugdev, jeffrey kasher, lilly
Dr Jeffrey Kasher has joined US healthcare tech firm DrugDev as the chairman of its advisory board. Kasher takes 28 …
China flu vaccine gets WHO seal of approval
June 12, 2015Research and Development, Sales and Marketing Hualan Biological Bacterin, WHO, influenza
A Chinese influenza vaccine has been deemed safe and effective by The World Health Organization (WHO). The approval makes its …
MSF campaigns to uphold cheap Indian generics
June 12, 2015Manufacturing and Production, Sales and Marketing Doctors Without Borders, India, MSF, Médecins Sans Frontières
Charity Médecins Sans Frontières is urging Indian prime minister Narendra Modi to stand tall and not give in to pressure …
Panasonic snaps up Bayer diabetes
June 12, 2015Medical Communications, Sales and Marketing Bayer, panasonic
Bayer is selling off its Diabetes Care business to Panasonic Healthcare Holdings, giving the Japanese giant access to blood glucose …
AstraZeneca head of R&D exits role
June 12, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Briggs Morrison
Briggs Morrison who joined AstraZeneca in 2012 and played an instrumental part in defending its takeover by Pfizer, is abruptly …
NHS could save £5 billion each year with modest reform
June 11, 2015Medical Communications, Sales and Marketing NHS, brett wells, lord carter
The chairman of the NHS procurement and efficiency board Lord Carter has said the UK health body could save billions …
Turing names R&D president
June 11, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing eliseo salinas, turing
Turing Pharmaceuticals has appointed life sciences executive and medical researcher Dr Eliseo Salinas to the company as president of R&D. …
NICE rejects Otelza but SMC recommends it
June 11, 2015Sales and Marketing Astellas, Celgene, NHS, NICE, SMC, Xtandi, otezla
Draft guidance issued by NICE has seen rejections for products including Celgene’s Otelza and Astellas Pharma’s Xtandi, and a call …
GSK investigator freed from Chinese prison
June 10, 2015Medical Communications, Sales and Marketing China, GSK, GlaxoSmithKline, brett wells, bribery, scandal
British private investigator Peter Humphrey who worked for GlaxoSmithKline has been released from a Chinese jail following his conviction last …
Data supports switching to Hospira biosimilar for RA
June 10, 2015Research and Development, Sales and Marketing EULAR, Hospira, Janssen, RA, brett wells, celltrion, inflectra, rome
Findings presented at EULAR this week from the first real-world study in patients with rheumatic diseases supports switching from J&J’s …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
